Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
155.70    5.50 (3.66%)
Bid:
156.50
Ask:
156.90
Spread: 0.40 (0.256%)
Market Cap: £1.62b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

2023 AGM Results - update statement

2 Feb 2024 09:51

RNS Number : 8757B
Currys PLC
02 February 2024
 

2 February 2024

CURRYS PLC

 

Further statement in relation to the AGM vote on our Directors' Remuneration Policy

 

The Board of Currys plc ('the Company') welcomed the 78.9% vote in favour of our Directors' Remuneration Report ("the Report") at the Annual General Meeting ("AGM") held on 7 September 2023. The vote in favour included the support from the majority of our shareholders, however the Board acknowledged that a significant minority of shareholders did not support this resolution.

 

Since the AGM, the Company has sought further engagement with our shareholders to discuss the specific rationale for the votes against our report. This engagement included the Chair of the Board meeting with several shareholders and the Company writing to other shareholders who voted against the Report inviting them to meet with the Chair of the Remuneration Committee and/or provide feedback.

 

The concerns expressed by those shareholders that have provided feedback related to:

· the level of bonus payments for 2022/23 given the assessment of business performance; and

· the choice of measures included in both the short and long-term incentives.

The Company's Remuneration Committee and the Board welcomed the opportunity to have constructive discussions on remuneration with our shareholders and note that our shareholders have opposing views and offer a range of different perspectives on our approach. 

The Remuneration Committee will consider the feedback received when assessing metrics for annual bonus and LTIP awards in the future and when evaluating future incentive outcomes and their alignment to performance achieved.

The Company's Remuneration Committee and the Board continue to believe that the Company's Directors' Remuneration Report and Remuneration Policy are appropriate in the context of incentivising our executive team, as they continue to deliver the Group's strategy.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKLLBBZLLZBBV
Date   Source Headline
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 202511:02 amRNSBoard committee change
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 202511:20 amRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20252:11 pmRNSResult of AGM
4th Sep 20257:00 amRNSAppointment of Rune Bjerke
4th Sep 20257:00 amRNSLaunch of £50m Share Buyback Programme
4th Sep 20257:00 amRNSStrong start to year, new £50m share buyback
1st Sep 20251:36 pmRNSTotal Voting Rights
20th Aug 20259:33 amRNSDirector/PDMR Shareholding
12th Aug 20252:41 pmRNSDirector/PDMR Shareholding
1st Aug 20259:30 amRNSTotal Voting Rights
31st Jul 20252:51 pmRNSDirector/PDMR Shareholding
31st Jul 202512:28 pmRNSHolding(s) in Company
31st Jul 202510:38 amRNSAnnual Financial Report
28th Jul 20252:02 pmRNSDirector/PDMR Shareholding
23rd Jul 20254:33 pmRNSDirector/PDMR Shareholding
23rd Jul 202511:15 amRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Jul 20257:00 amRNSStrengthening performance drives profit & cashflow
1st Jul 20251:18 pmRNSDirectorate Change
1st Jul 20258:10 amRNSTotal Voting Rights
12th Jun 20253:02 pmRNSHolding(s) in Company
3rd Jun 20254:19 pmRNSHolding(s) in Company
2nd Jun 202510:56 amRNSTotal Voting Rights
21st May 20257:00 amRNSFY Trading - Performance continues to strengthen
19th May 20253:23 pmRNSHolding(s) in Company
16th May 20253:43 pmRNSHolding(s) in Company
9th May 202510:00 amRNS-RYellowstone Advisory Private Investor Evening
1st May 20258:41 amRNSTotal Voting Rights
29th Apr 20254:37 pmRNSHolding(s) in Company
4th Apr 20251:43 pmRNSHolding(s) in Company
3rd Apr 20257:00 amRNSProfits expected to be above previous guidance
1st Apr 202510:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.